Analysis
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4348 (Published 07 August 2012) Cite this as: BMJ 2012;345:e4348
Related articles
- Analysis Published: 07 August 2012; BMJ 345 doi:10.1136/bmj.e4261
- PAPERS Published: 02 September 2005; BMJ doi:10.1136/bmj.38582.703866.AE
- Paper Published: 06 October 2005; BMJ 331 doi:10.1136/bmj.38582.703866.AE
- Education And Debate Published: 20 October 2005; BMJ 331 doi:10.1136/bmj.331.7522.958
- Letter Published: 04 September 2012; BMJ 345 doi:10.1136/bmj.e5880
- Feature Published: 17 February 2014; BMJ 348 doi:10.1136/bmj.g1533
- Editorial Published: 16 March 2018; BMJ 360 doi:10.1136/bmj.k1088
See more
- Scott Gottlieb resigns as head of FDABMJ March 07, 2019, 364 l1086; DOI: https://doi.org/10.1136/bmj.l1086
- Management of perinatal depression with non-drug interventionsBMJ February 25, 2019, 364 l322; DOI: https://doi.org/10.1136/bmj.l322
- US patients live longer in areas with more primary care doctors, study findsBMJ February 20, 2019, 364 l804; DOI: https://doi.org/10.1136/bmj.l804
- Improving outpatient antibiotic prescribingBMJ February 13, 2019, 364 l289; DOI: https://doi.org/10.1136/bmj.l289
- New York State moves to protect women’s abortion rightsBMJ January 31, 2019, 364 l520; DOI: https://doi.org/10.1136/bmj.l520
Cited by...
- Trump blames free riding foreign states for high US drug prices
- Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation?
- Why the drug development pipeline is not delivering better medicines
- Why do cancer drugs get such an easy ride?
- Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
- Patent wars: affordable medicines versus intellectual property rights
- Introduction
- NICE is dead; long live NICE
- Medicine In The Thrall Of The Culture Of Drugs
- Drug development: Innovation or imitation deficit?